27 May 2022 - - US-based clinical-stage biopharmaceutical company Xencor, Inc. (NASDAQ: XNCR) has reported initial dose-escalation data from the Phase 1 study evaluating XmAb104, a PD-1 x ICOS bispecific antibody, in patients with advanced solid tumo...
27 May 2022 - - US-based clinical-stage biopharmaceutical company Tvardi Therapeutics, Inc's lead product, TTI-101, has been granted Orphan Drug Designation by the US Food and Drug Administration for the treatment of idiopathic pulmonary fi...
27 May 2022 - - US-based clinical-stage biotechnology company Scioto Biosciences, Inc has released top-line results of its Phase Ib trial of lead asset, SB-121, based on its novel microbiome delivery platform, Activated Bacterial Therapeutics, w...
27 May 2022 - - The US Food and Drug Administration has accepted for filing and granted Priority Review of US-based clinical-stage biopharmaceutical company Reata Pharmaceuticals, Inc's (NASDAQ: RETA) New Drug Application for omaveloxolone ...
27 May 2022 - - The US Food and Drug Administration has granted Fast Track designation to US-based pharmaceutical company Pfizer Inc's (NYSE: PFE) investigational combination therapy for the treatment of non-alcoholic steatohepatitis with l...